The purpose of this article is to illustrate the cross-sectional imaging appearance of postradiation changes and complications of radiotherapy in the head and neck. Radiotherapy is an important treatment modality for head and neck cancer, and is often used in conjunction with chemotherapy. Recognition of the varied effects of radiotherapy to the head and neck region is essential to correctly interpret posttreatment imaging and may help prevent further complication.
Introduction
Radiotherapy has become an important treatment modality for head and neck cancer, and is often used in combined modality therapy with surgery and/or chemotherapy. Radiation therapy in the head and neck is used in the treatment of a diverse spectrum of neoplasms, including nasopharyngeal cancer, squamous call carcinoma in multiple sites, other sinonasal neoplasms, major and minor salivary neoplasms, lymphoma, and metastases. Radiation therapy protocols vary, depending on the type of neoplasm, presence or absence of nodal disease, and institutional preference.
Because many of these patients receive routine follow-up imaging for surveillance of their treated disease, familiarity with the typical imaging appearance of radiotherapy changes and potential complications is essential. Surveillance imaging in these patients is typically performed with computed tomography (CT) or magnetic resonance imaging (MRI), therefore, this pictorial essay emphasizes the imaging appearance of postradiotherapy effects depicted on standard anatomic imaging studies. CT and MR (magnetic resonance) are complementary techniques in evaluating the head and neck region. Whereas MR has the advantage of superior soft-tissue contrast, CT provides higher spatial resolution, better assessment of bone detail, and less susceptibility to motion artifact, and is often more readily available. Intravenous contrast is extremely helpful in revealing the full extent of pathology and is used routinely as long as there is no contraindication.
A typical CT imaging protocol includes enhanced volumetric images acquired from the aortic arch to above the frontal sinus, with 2-mm axial reconstructions and coronal and sagittal reformats, by using bone and soft-tissue algorithms. A typical MR protocol includes sagittal, axial, and coronal T1-weighted images; axial and coronal T2 fat-saturated (FS) images; and postcontrast axial and coronal T1 FS imaging. There has been continued progress in the application of physiological imaging, such as diffusion-weighted imaging [1] , CT perfusion [2] , MR perfusion and/or permeability, and molecular imaging methods such as positron emission tomography (PET) to the study of head and neck pathology [3] ; these methods show great promise in differentiating posttreatment change from tumour recurrence. PET-CT is becoming increasingly established in the postradiation follow up of head and neck cancer, with negative studies having a very high negative predictive value for recurrence [4] . However, a detailed discussion of these functional methods is beyond the scope of this article.
It should be noted that to properly interpret posttreatment studies, it is essential for the radiologist to be aware of the timing, duration, dose, and location of treated tissues; the site, local extent, and histology of the original neoplasm; and any other modalities of therapies that have been used.
Tissue Oedema
Any trauma to the neck can produce tissue oedema, presumably on the basis of vascular or lymphatic disruption. Early postradiotherapy change is characterized by an acute inflammatory reaction, with leukocytic infiltration, histiocyte formation, necrosis, and tissue hemorrhage. The imaging appearance is that of skin thickening, reticulation and stranding in the subcutaneous tissues, and increased overall attenuation of the subcutaneous fat because of increased interstitial fluid content [5] . In addition, there often is mild diffuse swelling and oedema of the mucosa of the hypopharynx and larynx, oedema of the epiglottis, and a thin slip of retropharyngeal fluid and/or oedema ( Figure 1 ) [6] . These changes often fully manifest after the first month after cessation of therapy. The extent and duration of these findings is highly variable.
Mucosal Changes
Mucositis is a clinical term for radiotherapy-and chemotherapy-induced inflammation of the oral and pharyngeal mucosa. Mucositis can result directly from damage to the epithelial tissues (''direct mucositis'') or can be a result of infection of tissues rendered susceptible by the effects of therapy (''indirect mucositis''). Symptoms mainly consist of pain, discomfort, and difficulty tolerating food. The diagnosis is clinical; imaging may be performed to look for a complication, such as perforation or neck infection. Typical imaging findings include thickening and hyperenhancement of the pharyngeal mucosa ( Figure 2 ) [5, 7] .
In the subacute and chronic phases, months to years after therapy, persisting hyperemia may be seen, presumably because of radiation-induced telangiectasias. Other findings include mucosal atrophy and soft-tissue ulceration and/or necrosis ( Figure 3 ). It can be difficult to distinguish benign postradiation soft-tissue necrosis from malignant ulceration. It has been reported that, for postradiation soft-tissue ulceration, if there is no clinical evidence of recurrence and no enhancement, then benign ulceration is more likely and follow-up rather than biopsy may be appropriate [8] .
Occasionally, chronic mucositis can cause the formation of exuberant granulation tissue in the form of granulomatous polyps [9] , which can mimic recurrence. In the late phase, fibrosis and/or scarring can occur and can result in pharyngeal stenosis ( Figure 4 ).
Glandular Changes
Salivary gland injury is a frequent complication of radiation therapy. Radiation-induced xerostomia is a serious complication of radiation therapy. Xerostomia increases the risk for dental caries, can exacerbate mucositis, and is associated with significant discomfort and reduced quality of life. Early radiation injury to the parotid and submandibular glands, termed acute radiation parotitis, manifests as tenderness, swelling, pain, and xerostomia. Late radiation injuries generally present as transient or permanent xerostomia. Changes in the morphology of irradiated salivary glands are frequently seen at imaging and include hyperemia, in a heterogeneous pattern early on, and later, atrophy and volume loss, which may be accompanied with fatty infiltration ( Figure 5 ).
Physiological imaging techniques have shown promise as a means to characterize radiation injury to the salivary glands. It has been shown that the tissue apparent diffusion coefficient (ADC) values of irradiated parotid glands are higher than preradiotherapy levels, and the normal biphasic ADC response to salivary stimulation (initial drop in ADC followed by gradual increase) is lost in the irradiated glands, which correlated with salivary function by using scintigraphy [10] . Dynamic contrast-enhanced MR (MR perfusion) of the parotids in radiotherapy patients with symptomatic xerostomia displayed decreased perfusion parameters and higher time to peak and peak enhancement of the irradiated glands, indicating gradual and prolonged accumulation and delayed washout of contrast [11] . Pituitary gland dysfunction can occur after skullbase radiotherapy. Imaging is usually normal in these cases [9] .
Radiation Injury to Lungs
The lung apices are often covered in radiation treatment for head and neck malignancy, and are also often partially imaged on head and neck imaging studies ( Figure 6 ). The diverse spectrum of imaging changes caused by radiation injury to the lungs has been covered thoroughly elsewhere and is not the focus of this article [12] .
Radiation Changes in Bone
The most common osseous abnormality seen in irradiated bone is radiation-induced fatty replacement of marrow [6] . These changes are asymptomatic and manifest as increased marrow signal on T1-weighted images. These changes can be seen at doses as low as 800 cGy [13] .
At higher doses (usually >6000 cGy), radiation injury to bone in skeletally mature patients can produce changes that have been termed radiation osteitis, osteoradionecrosis, and radiation necrosis. Radiation injury impairs osteoblast function and results in decreased matrix production and resorption of bone matrix. There is progressive endothelial cell death, thrombosis of small vessels, and fibrosis of periosteum and marrow spaces. On radiographic examination, initial imaging may be normal or may show osteopenia, which is generally seen in the first year. Next, there is a reparative response with bone deposition on unresorbed trabeculae. This results in a mottled appearance with areas of patchy lucency and sclerosis and coarsening of trabeculae. These findings can resemble Paget disease, however, without bony expansion [14] .
Over time, there can be progressive necrosis and development of bony sequestration. On CT, a mottled appearance is typical, with patchy lucency and sclerosis, and cortical irregularity (Figures 7 and 8) . On MR, the affected bone demonstrates mixed signal with irregular enhancement. Pathologic fractures can be seen. The differential diagnosis includes osteomyelitis, which can have a similar appearance but which can often be distinguished clinically. The absence of a soft-tissue mass separate from the bony abnormality can help to distinguish osteonecrosis from tumour. 
Chondronecrosis
In addition to the changes of oedema, mucositis, and fibrosis described above, high-dose (usually >6000 cGy) radiation to the laryngeal structures can be associated with perichondritis and chondronecrosis. Perichondritis is an inflammatory or infection process that involves irradiated cartilage. It may lead to collapse and/or necrosis of the laryngeal cartilages, termed chondronecrosis. Imaging may show oedema surrounding the cartilage structures, and, occasionally, small gas bubbles may be seen. In the later stages of chondronecrosis, there will be fragmentation and structural collapse of the laryngeal cartilage (Figure 9 ). Chondronecrosis can be precipitated by biopsy of the irradiated larynx. Fragmentation should be judged carefully and with reference to prior examinations, because there can be marked variability in the degree of ossification of laryngeal structures as a normal variant. It should also be noted that cartilage invaded by tumour may collapse after radiation because of regression of tumour, which has replaced the cartilage framework rather than true chondronecrosis [15] .
Radiation Injury to the Nervous System
Radiation injury to the brain is one of the most serious adverse effects of radiotherapy. The most commonly involved areas are the inferomedial temporal lobes, which are often affected because of their close relationship to the skull base. In patients with nasopharyngeal cancer who had skull-base radiation and developed radiation injury to brain, involvement is bilateral in approximately two-thirds [9] . Temporal lobe radiation injury usually occurs after high-dose (>5000 cGy) therapy, at a median interval of 5 years. On pathologic examination, there is oedema, demyelination, reactive gliosis followed by cavitation and necrosis. The most common imaging finding is white matter T2-signal hyperintensity, which corresponds to myelin rarefaction, gliosis, and oedema, particularly when accompanied by mass effect (Figure 10 ). Grey matter lesions also occur but are less marked [16] . Frank radiation necrosis is characterized by heterogeneous white matter changes, foci of low T2 signal and/or hemorrhage, cystic areas, and enhancement ( Figure 11 ). The imaging changes tend to remain static or progress slowly. Steroid treatment is used to reduce oedema.
In contrast to treated brain malignancies, in which distinguishing between radiation necrosis and recurrent tumour is often a diagnostic challenge, in the setting of head and neck cancer (typically nasopharyngeal cancer), the location, bilaterality, and imaging appearance of temporal lobe radiation injury is often characteristic. The brain is frequently normal before treatment, and direct invasion and hematogenous metastases to brain are rare. Nevertheless, functional techniques such as MR spectroscopy, perfusion, and PET imaging may have value in distinguishing radiation necrosis from tumour and infection. MR spectroscopy may show reduction in N-acetyl-aspartate and choline, a lactate peak may be present, and a 2.4-ppm peak, which may represent succinate, may be present. PET imaging tends to show higher metabolic activity in recurrent tumours, but overlap exists [9, 17] .
Radiation-induced optic neuropathy is a rare but devastating complication. It is thought to be a result of radiation necrosis of the anterior visual pathway. It generally results in acute, profound, irreversible vision loss 12e18 months after radiotherapy. Cumulative doses higher than 5000 cGy or single doses higher than 1000 cGy are usually needed. The most characteristic finding is enhancement of the optic nerve (Figure 12 ). T1 and T2 signal is often normal, although occasionally swelling and oedema will be seen in the acute phase. In the chronic phase, optic atrophy takes place. Radiation-induced lower cranial nerve injury is uncommon. The mechanism is not well defined. Compression caused by fibrosis surrounding the carotid sheath has been implicated.
Another complication of radiotherapy is the development of vascular lesions, which have been described as telangiectasias and cavernous malformations. Their development seems to be more common in pediatric patients but can be seen in adults. These may represent the sequela of attempted recruitment of collateral vessels because of radiation-induced small-vessel occlusion, and subclinical hemorrhage. Often, these lesions have the typical appearance of cavernomas with blooming on gradient and susceptibility weighted images ( Figure 13 ). They are frequently asymptomatic [13] .
Large Vessel Disease
Large vessel vasculopathy is less common than the small vessel disease, which underpins many of the effects noted above. The mechanism is thought to be a combination of radiation-induced intimal hyperplasia, vascular thrombosis, and accelerated atherosclerosis. The changes are generally seen only after high-dose therapy (>5000 cGy), with a widely variable latency period. Arterial stenoses and occlusions of the intracranial or extracranial circulation are the most common finding, depending on the site of radiation therapy (Figure 14 ). Pseudoaneurysms and arterial blowouts are well known but rare complications ( Figure 15 ) [13] .
Radiation-Induced Neoplasms
Radiation-induced neoplasms are rare. Although meningiomas are the most common radiation-induced intracranial neoplasm, in the adult head and neck literature, the two most commonly reported radiation-induced neoplasms are sarcomas and squamous cell carcinomas. For a diagnosis of radiationinduced neoplasm to be made, the neoplasm must be within the radiation field, must differ in histology from the treated primary, must occur with higher prevalence in radiation therapy patients, and must occur after a sufficient latency period [13] . Sarcomas tend to occur with a latency period of 5e10 years and have varied histologies, including osteosarcoma, malignant fibrous histiocytoma, chondrosarcoma, and malignant nerve sheath tumours (Figures 16 and 17 ). Squamous cell carcinomas tend to occur with a latency of more than 10 years and have a predilection for the temporal bone and external auditory canal. Both tend to present as masses. Surgical resection is the only chance of cure; the prognosis is poor. Other radiation-induced neoplasms include osteochondromas and thyroid malignancies, although causation may be difficult to establish in the latter case.
Conclusion
Radiotherapy remains a mainstay of treatment for head and neck malignancy. The effects of radiation treatment to the head and neck for cancer treatment are varied. The most common and most important entities encountered in the head and neck have been presented, including soft-tissue, salivary gland, and mucosal changes; damage to osseous and cartilaginous structures; injury to the nervous system; small and large vessel vasculopathy; and radiation-induced neoplasms. Many of these findings may be first recognized radiologically, therefore, familiarity with the spectrum of postradiotherapy change is essential.
